BAYERCROPPesticides & Agrochemicals
Bayer CropScience Ltd — Profit & Loss Statement
₹4645.60
-1.50%
Bayer CropScience Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 8.28 Cr | -2.24 Cr | 25.46 Cr | 14.35 Cr | — |
| Tax Rate For Calcs | 0.20 | 0.21 | 0.23 | 0.24 | — |
| Normalized EBITDA | 767.30 Cr | 1.05K Cr | 983.20 Cr | 863.90 Cr | — |
| Total Unusual Items | 42.00 Cr | -10.50 Cr | 108.70 Cr | 60.30 Cr | — |
| Total Unusual Items Excluding Goodwill | 42.00 Cr | -10.50 Cr | 108.70 Cr | 60.30 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 568.00 Cr | 740.50 Cr | 758.20 Cr | 645.30 Cr | — |
| Reconciled Depreciation | 84.90 Cr | 74.00 Cr | 79.50 Cr | 64.50 Cr | — |
| Reconciled Cost Of Revenue | 3.43K Cr | 2.94K Cr | 2.85K Cr | 2.68K Cr | — |
| EBITDA | 809.30 Cr | 1.03K Cr | 1.09K Cr | 924.20 Cr | — |
| EBIT | 724.40 Cr | 961.00 Cr | 1.01K Cr | 859.70 Cr | — |
| Net Interest Income | 39.60 Cr | 28.80 Cr | 11.70 Cr | 11.60 Cr | — |
| Interest Expense | 17.00 Cr | 19.60 Cr | 22.30 Cr | 12.90 Cr | — |
| Interest Income | 56.60 Cr | 48.40 Cr | 34.00 Cr | 24.50 Cr | — |
| Normalized Income | 534.28 Cr | 748.76 Cr | 674.96 Cr | 599.35 Cr | — |
| Net Income From Continuing And Discontinued Operation | 568.00 Cr | 740.50 Cr | 758.20 Cr | 645.30 Cr | — |
| Total Expenses | 4.70K Cr | 3.98K Cr | 4.09K Cr | 3.82K Cr | — |
| Rent Expense Supplemental | 10.20 Cr | 13.60 Cr | 12.00 Cr | 11.40 Cr | — |
| Diluted Average Shares | 4.49 Cr | 4.49 Cr | 4.49 Cr | 4.49 Cr | — |
| Basic Average Shares | 4.49 Cr | 4.49 Cr | 4.49 Cr | 4.49 Cr | — |
| Diluted EPS | 126.38 | 164.77 | 168.71 | 143.58 | — |
| Basic EPS | 126.38 | 164.77 | 168.71 | 143.58 | — |
| Diluted NI Availto Com Stockholders | 568.00 Cr | 740.50 Cr | 758.20 Cr | 645.30 Cr | — |
| Net Income Common Stockholders | 568.00 Cr | 740.50 Cr | 758.20 Cr | 645.30 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 568.00 Cr | 740.50 Cr | 758.20 Cr | 645.30 Cr | — |
| Net Income Including Noncontrolling Interests | 568.00 Cr | 740.50 Cr | 758.20 Cr | 645.30 Cr | — |
| Net Income Continuous Operations | 568.00 Cr | 740.50 Cr | 758.20 Cr | 645.30 Cr | — |
| Tax Provision | 139.40 Cr | 200.90 Cr | 231.90 Cr | 201.50 Cr | — |
| Pretax Income | 707.40 Cr | 941.40 Cr | 990.10 Cr | 846.80 Cr | — |
| Other Non Operating Income Expenses | 16.60 Cr | 14.80 Cr | 12.10 Cr | 14.80 Cr | — |
| Special Income Charges | 22.90 Cr | -25.30 Cr | 95.20 Cr | 50.90 Cr | — |
| Other Special Charges | -25.60 Cr | 2.40 Cr | -104.30 Cr | -57.90 Cr | — |
| Write Off | 2.70 Cr | 3.80 Cr | 9.00 Cr | 5.30 Cr | — |
| Impairment Of Capital Assets | 0.00 | 19.10 Cr | 0.10 Cr | 1.70 Cr | — |
| Net Non Operating Interest Income Expense | 39.60 Cr | 28.80 Cr | 11.70 Cr | 11.60 Cr | — |
| Interest Expense Non Operating | 17.00 Cr | 19.60 Cr | 22.30 Cr | 12.90 Cr | — |
| Interest Income Non Operating | 56.60 Cr | 48.40 Cr | 34.00 Cr | 24.50 Cr | — |
| Operating Income | 609.40 Cr | 908.50 Cr | 859.80 Cr | 760.30 Cr | — |
| Operating Expense | 1.28K Cr | 1.04K Cr | 1.23K Cr | 1.13K Cr | — |
| Other Operating Expenses | 346.50 Cr | 238.00 Cr | 240.30 Cr | 207.40 Cr | — |
| Depreciation And Amortization In Income Statement | 84.90 Cr | 74.00 Cr | 79.50 Cr | 64.50 Cr | — |
| Amortization | 2.90 Cr | 1.90 Cr | 1.50 Cr | 0.70 Cr | — |
| Depreciation Income Statement | 82.00 Cr | 72.10 Cr | 78.00 Cr | 63.80 Cr | — |
| Selling General And Administration | 520.40 Cr | 475.50 Cr | 550.50 Cr | 532.50 Cr | — |
| Selling And Marketing Expense | 384.90 Cr | 328.70 Cr | 421.50 Cr | 429.50 Cr | — |
| General And Administrative Expense | 135.50 Cr | 146.80 Cr | 129.00 Cr | 103.00 Cr | — |
| Rent And Landing Fees | 10.20 Cr | 13.60 Cr | 12.00 Cr | 11.40 Cr | — |
| Gross Profit | 1.89K Cr | 1.95K Cr | 2.09K Cr | 1.89K Cr | — |
| Cost Of Revenue | 3.43K Cr | 2.94K Cr | 2.85K Cr | 2.68K Cr | — |
| Total Revenue | 5.31K Cr | 4.89K Cr | 4.94K Cr | 4.58K Cr | — |
| Operating Revenue | 5.31K Cr | 4.89K Cr | 4.94K Cr | 4.58K Cr | — |
| Restructuring And Mergern Acquisition | — | — | — | 0.00 | -5.10 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Bayer CropScience Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.